The largest database of trusted experimental protocols

Gene pulser xcell device

Manufactured by Bio-Rad
Sourced in United States, Belgium

The Gene Pulser Xcell device is a laboratory instrument used for the electroporation of cells. It applies controlled electrical pulses to facilitate the introduction of DNA, RNA, or other molecules into the cells. The device allows for the optimization of electroporation parameters to enhance the efficiency of the process.

Automatically generated - may contain errors

21 protocols using gene pulser xcell device

1

Bacterial Transformation via Electroporation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before electroporation, 20 μl of the DNA solution was placed on a Millipore VSWP02500 membrane (25 mm diameter, 0.025 μm porosity) floating on a Petri dish filled with 40 ml of ultrapure sterile water. After 1 hour of dialysis, the droplet is recovered by pipetting. 1 μl of dialyzed DNA was mixed with 50μl electro-competent E. coli Top 10 cells in pre-chilled 1 mm electrodes distance Gene Pulser cuvette (Biorad) and the electroporation was then performed with Gene Pulser Xcell device (voltage 1800V, capacitance 25μF, resistance 200 ohm). Electroporated cells were recovered with 1ml of LB and incubated at 37 C with orbital shaking during 45 minutes before plating on LB plates containing the appropriate antibiotics. The number of transformants is estimated by plating serial 10-fold dilutions and counting colony forming units (cfu) after overnight incubation at 37 C. Typically, between 106 and 107 cfu were obtained per electroporation. Alternatively, the DNA was concentrated at least 10-fold using the “DNA Clean & Concentrator-5” kit from Zymo Research and up to 108 cfu can be obtained with 5 μl in a single electroporation.
+ Open protocol
+ Expand
2

Plasmid DNA Extraction and Transformation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid DNA was extracted using the EZ-10 Spin Column Plasmid DNA Minipreps kit (Bio Basic) following the manufacturer’s instructions. Enzymes used in this study were purchased from New England Biolabs. PCR assays were performed with the primers listed in Table 2. PCR conditions were as follows: (i) 3 min at 94°C; (ii) 30 cycles, with 1 cycle consisting of 30 s at 94°C, 30 s at the appropriate annealing temperature, and 1 min/kb at 68°C; and (iii) 5 min at 68°C. When required, the resulting products were purified using the EZ-10 Spin Column PCR Products purification kit (Bio Basic) following the manufacturer’s instructions. E. coli strains were transformed by electroporation as described previously (64 (link)) in a Bio-Rad Gene Pulser Xcell device set at 25 μF, 200 V, and 1.8 kV using 1-mm gap electroporation cuvettes.
+ Open protocol
+ Expand
3

WT1 Overexpression in Mature CBDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mature CBDC were loaded with WT1-encoding mRNA (AmpTec GmbH) by electroporation (EP) as previously described (24 (link)), with minor modifications. Briefly, 5–10×10e6 cells in 200 µl OptiMEM media were transferred to a 4-mm electroporation cuvette (Bio-Rad, Hercules, CA, USA) and electroporated with 9,5 ug RNA by a time constant pulse of 300 V for 7 ms using the Gene Pulser Xcell device (Bio-Rad). After EP the cells recovered for 4h in the medium used to mature the cells. Next, WT1 expression was determined. Cells were washed with FACS buffer (PBS containing 2% BSA (Sigma-Aldrich) and 0.1% sodium azide (NaN3, Sigma-Aldrich) prior to a 15 min incubation at room temperature (RT) in the dark with a fixable viability dye (Thermo fisher). Next, cells were washed and fixed/permeabilized (eBioscience) for 30 min at 4°C. After washing with permeabilization buffer, anti-WT1 (F6-H2; (Dako) or purified mouse IgG1κ (MG1-45; Biolegend) as isotype control and FcR Blocking (Miltenyi Biotec) was added for 15 min at RT in de dark. The cells were washed again with permeabilization buffer before adding the F(ab’)2 Anti-mouse IgG PE antibody (eBioscience) for 15 min at RT in the dark. Cells are resuspended in FACS buffer and analyzed using a FACS CantoII (BD) flow cytometer. Analysis was performed using FlowJo software (Tree Star, Inc.).
+ Open protocol
+ Expand
4

Optimized qPCR Primer Design and RRP40 Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR primers were designed using ‘qPCR’ settings in Primer 3 Plus (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi, i.e. for an optimal primer length of 20–22 nt, a melting temperature of 62°C, and amplimers of 100–300 bp). Primer sequences are available on request. For the RRP40 knock-down, previously tested siRNAs (21 (link)) were introduced into HUVECs by electroporation using the GenePulser XCell device (Bio-Rad) at 250 mV with 1 × 20-ms square pulse (‘KD1’), or 350 mV with 1× exponential pulse at 350 μF (‘KD2’), on ∼1 million cells/ml per hit in 4-mm cuvettes; cells were then transferred to 15-cm plates and grown for ∼36 h before RNA was harvested.
+ Open protocol
+ Expand
5

Electroporation of BCBL-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
1 × 107 BCBL-1 cells were grown in antibiotic-free RPMI. The next day, they were pelleted and rinsed twice in PBS. The cell suspension was transferred into a 0.4 cm electrode gap cuvette with 10 μg of TrueORF Gold pCMV6-Entry DNA vector (Origene, Rockville, MD, USA) containing the Myc-DDK (FLAG)-tagged helicase of interest (Origene, Rockville, MD, USA) or pmaxGFP (AddGene, Cambridge, MA, USA). Cuvettes were treated 2 times at 250 V, 950 μF with the Gene Pulser Xcell device (Bio-Rad, Hercules, CA, USA). Electroporated BCBL-1 cells were grown for 48 h in non-selective RPMI medium. After the 48 h, media was replaced with RPMI containing 400 μg/mL G418 for 4 weeks.
+ Open protocol
+ Expand
6

Electroporation of mRNA into moDCs and T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection of mRNA to moDCs and T cells was performed by electroporation. Cells were extensively washed in serum-free OptiMEM (Life Technologies, Belgium). The electroporation was performed in 200 μL of OptiMEM medium in a 4-mm electroporation cuvette (Cell Projects) using the following parameters: square wave pulse, 500 V, 2 ms, 1 pulse for moDCs; and square wave pulse, 500 V, 5 ms, 1 pulse for T cells, using the Gene Pulser Xcell device (Bio-Rad, Belgium). TCRα- and TCRβ-chain mRNA (5 μg each/106 cells) was electroporated into CD8+ T cells. Electroporation of moDCs with mRNA was performed with a total concentration of 100 μg/mL mRNA.
+ Open protocol
+ Expand
7

Isolation and Transfection of Primary Oligodendrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary oligodendrocytes were obtained from C57BL/6 mice at embryonic day 14-16 as described previously [16] (link). The primary cells were grown on poly-L-lysine-coated culture vessels in B27 medium containing 1% (v/v) horse serum (life technologies), 10 ng/ml Platelet-Derived Growth Factor-AA and 5 ng/ml basic Fibroblast Growth Factor (both from tebu-bio). The oligodendroglial cell line Oli-neu[17] (link) was grown in Sato medium containing 1.5% (v/v) horse serum, also on poly-L-lysine-coated culture vessels.
Oli-neu cells were transfected with plasmids using a Gene Pulser Xcell device (Bio-Rad). 10 µg of plasmid DNA were added to 1.8–2 million cells in culture medium and electroporated at 220 V and 950 microfarads (exponential decay program). A medium change was carried out 16–20 hours following transfection. siRNA transfections were carried out with the Basic Nucleofector Kit for Primary Mammalian Neurons (Lonza) according to the manufacturer’s instructions. 160 pmol siRNA were used with 4 million primary oligodendrocytes or 1 million Oli-neu cells, respectively.
+ Open protocol
+ Expand
8

Electroporation of T Cells for Gene Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before electroporation, 10 × 106 viable 2D3 or human primary unstimulated CD8+ T cells were washed twice in cold serum-free Opti-MEM I medium (Gibco Invitrogen), resuspended in 200 μL of the same medium and transferred to a 4.0 mm electroporation cuvette (Cell Projects). Next, one microgram of in vitro transcribed mRNA per 106 cells and/or a 100 μM pool of two DsiRNA against the wild-type sequences of the T-cell receptor constant alpha and beta regions (TRAC and TRBC) in a 1:1 ratio, or a control DsiRNA against EGFP (Integrated DNA Technologies) were added to the cuvette. Electroporations were performed in a Gene Pulser Xcell™ device (Bio-Rad Laboratories) using Square Wave protocol (500 V, 5 ms, 0 gap, 1 pulse). As a negative control, cells were electroporated under the same conditions without the addition of any RNA (“Mock”). Immediately after electroporation, cells were transferred to 5 mL of RPMI medium supplemented with 10% FBS (2D3 cells) or AIM-V medium (Gibco Invitrogen) with 10% human AB serum (Gibco Invitrogen) (CD8+ T cells) and incubated for a minimum of 20 min at 37°C and 5% CO2 prior to analysis. For further analysis, cells were centrifuged and resuspended in RPMI supplemented with 5% FBS (Jurkat E6-1 or 2D3 cells) or AIM-V medium with 5% human AB serum (primary CD8+ T cells).
+ Open protocol
+ Expand
9

Optimized Transfection of Primary T Cells and Jurkat Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human CD4+ T cells were transfected directly after isolation using the Amaxa Nucleofector I device and the human T cell Nucleofector Kit (#VPA-1002, Lonza). Transfection was performed according to the instructions of the manufacturer (program V24, 5μg vector DNA or 300nM small interfering RNA (siRNA), respectively). Jurkat E6.1 T lymphocytes (1x107 per sample) were transfected using the Gene Pulser X cell device equipped with a CE module (Bio-Rad) and 4mm cuvettes (Bridge). Transfection with 10–30μg plasmid DNA was carried out in 500μl RPMI-1640 (GE Healthcare) with 50% FCS (Sigma) using an exponential protocol (240V, 1500μF). Cells were used for functional assays 24h (transfection with DNA) or 48h (transfection with siRNA) later and cultured without antibiotics post-transfection. RNA interference was performed using oligonucleotides with the following sense sequences:
5’-GGUGCCUGUAGGUGAUCAA(dTdT)-3’ (human Dynamin2, oligo #1),5’-GCACUCUGUAUUCUAUUAA(dTdT)-3’ (human Dynamin2, oligo #2),5’-AAACAUGCAGAAAAUGCUG(dTdT)-3’ (Renilla luciferase, control siRNA).All siRNAs were purchased from Quiagen or Dharmacon RNA Technologies, respectively.
+ Open protocol
+ Expand
10

Generation of IL-15 Designer Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DC were generated as described previously [25 (link), 26 (link)] with minor adaptations specific for the IL-15 designer DC. Briefly, positively selected CD14+ monocytes were differentiated into immature DC in the presence of IL-4 (20 ng/mL; Life Technologies) and granulocyte-macrophage colony-stimulating factor (800 U/mL; Gentaur) in Roswell Park Memorial Institute 1640 (RPMI; Invitrogen) supplemented with 2.5% human AB serum (SanBio). After 5 days, 20 ng/mL tumor necrosis factor-α (Gentaur) and 2.5 μg/mL prostaglandin E2 (Pfizer, Puurs, Belgium) were added to induce maturation. Monocyte-derived DC (moDC) were harvested 40–44 hours later and electroporated by a time-constant (7 ms) pulse of 300 V using the Gene Pulser Xcell device (Bio-Rad) either without mRNA (mock EP DC), with 5 μg OSP-IL-15 mRNA (IL-15 EP DC), or with a combination of 5 μg OSP-IL-15 mRNA and 5 μg IL-15Rα mRNA (IL-15/IL-15Rα EP DC) in 200 μL Opti-MEM reduced serum medium without phenol red (Life Technologies). Immediately after electroporation, DC were resuspended in prewarmed Iscove's Modified Dulbecco's Medium (IMDM; Invitrogen) + 10% fetal bovine serum (FBS) for further use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!